Literature DB >> 30025709

Procyanidin B2 protects rats from paraquat-induced acute lung injury by inhibiting NLRP3 inflammasome activation.

Yinling Jiang1, Wanchun Yang1, Shuyu Gui2.   

Abstract

Paraquat is a commonly used heterocyclic herbicide and has high toxicity by causing acute lung injury. There is no effective treatment for paraquat poisoning. We evaluated the effects of procyanidin B2, a natural dietary phytochemical, on paraquat-induced lung injury in rats. Paraquat was used to induce acute lung injury of rats, which were administered with procyanidin B2. The lung injury was evaluated by measuring the lung/body weight ratio, the histology and PMNs count. The oxidative stress was assessed by detecting ROS-mediated indices in the BALF. The expression of IL-1β and IL-18 were detected by RT-PCR and ELISA. The levels of NLRP3 inflammasome components including NLRP3, ASC and caspase-1 were detected by western blot. The lung injury in the paraquat-induced models in NLRP3 gene silenced animals was compared with the same lung injury model treated with procyanidin B2. Administration of procyanidin B2 significantly reduced paraquat-induced lung injury with lower BALF PMNs count, MPO activity, MDA level and elevated SOD activity. Procyanidin B2 suppressed expression of IL-1β and IL-18 at both RNA and protein levels, similar to the NLRP3 gene silenced rats. Compared to paraquat-induced group, procyanidin B2 showed remarkably decreased NLRP3, ASC and caspase-1 signals in the lung tissues in a dose-dependent manner. Procyanidin B2 significantly suppressed the activation of NLRP3 inflammasome in the lung tissue induced by paraquat in the rat model. This finding revealed a novel mechanism by which procyanidin B2 exerts anti-inflammatory effects and their clinical benefits in health.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acute lung injury; NLRP3 inflammasome; Oxidative stress; Paraquat poisoning; Procyanidin B2

Mesh:

Substances:

Year:  2018        PMID: 30025709     DOI: 10.1016/j.imbio.2018.07.001

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

Review 1.  Inflammasome Activation in Parkinson's Disease.

Authors:  Shannon Jewell; Ashane M Herath; Richard Gordon
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

2.  Mitochondrial PKM2 deacetylation by procyanidin B2-induced SIRT3 upregulation alleviates lung ischemia/reperfusion injury.

Authors:  Jing Zhao; Guorong Wang; Kaitao Han; Yang Wang; Lin Wang; Jinxia Gao; Sen Zhao; Gang Wang; Shengyang Chen; An Luo; Jianlin Wu; Guangzhi Wang
Journal:  Cell Death Dis       Date:  2022-07-11       Impact factor: 9.685

Review 3.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

4.  Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation.

Authors:  Cai Zhang; Xinran Wang; Chunguo Wang; Cheng He; Quantao Ma; Jialin Li; Weiling Wang; Yan-Tong Xu; Ting Wang
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

5.  Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing.

Authors:  Min-Na Dong; Yun Xiao; Yun-Fei Li; Dong-Mei Wang; Ya-Ping Qu; Tian-Wen Fang; Hui Li; Ming-Wei Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

6.  Metabolomic Analysis, Fast Isolation of Phenolic Compounds, and Evaluation of Biological Activities of the Bark From Weinmannia trichosperma Cav. (Cunoniaceae).

Authors:  Ruth Barrientos; Carlos Fernández-Galleguillos; Edgar Pastene; Mario Simirgiotis; Javier Romero-Parra; Shakeel Ahmed; Javier Echeverría
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.